Selecta Biosciences, Inc. (SELB)
(Delayed Data from NSDQ)
$2.35 USD
+0.23 (10.85%)
Updated May 3, 2019 04:00 PM ET
After-Market: $2.36 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
Cartesian Therapeutics, Inc. [SELB]
Reports for Purchase
Showing records 1 - 20 ( 35 total )
Company: Cartesian Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Pipeline Programs Pared; 2Q23 Financial Results Reported; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Cartesian Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
SEL-212 Approaches Filing; Restructuring to Reduce Costs; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Cartesian Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
SEL-212 DISSOLVE Program Meets Primary Endpoints; Raising PT to $5
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Cartesian Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
SEL-212 Pivotal Data Nears; Pipeline Expands; 2022 Financials; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Cartesian Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
IgA Nephropathy Program Candidate Unveiled; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Cartesian Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
DISSOLVE Readouts Approaching; 3Q22 Financials; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Cartesian Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Biotechnology - Ever Evolving Genetic Medicines
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Cartesian Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
DISSOLVE Program Nearing Conclusion; 2Q22 Financials; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Cartesian Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Sarepta Agreement Expanded; DISSOLVE Program Advancing; Lowering PT to $4
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Cartesian Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Additional Partnership Inked With Ginkgo Bioworks; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Cartesian Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
DISSOLVE I Study Completes Patient Enrollment; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Cartesian Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Clinical Hold Reaction Appears Excessive; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Cartesian Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
ImmTOR Gene Vector Data Appears Promising; 3Q21 Financials; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Cartesian Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Partnership Inked With Ginkgo Bioworks; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Cartesian Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Strategic Licensing Agreement Inked With Genovis; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Cartesian Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Strategic Licensing Agreement Inked With Takeda; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Cartesian Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Cartesian Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Cyrus Biotechnology Collaboration Agreement Announced; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Cartesian Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
SEL-399 Data Next Quarter; 2Q21 Financial Results; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Cartesian Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Publication Underscores ImmTOR Tolerability and Efficacy; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R